ArticleIranian journal of public health2025
Patterns of Mortality among People with Autism Spectrum Disorder in South Korea.
Article in Iranian journal of public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Detailed statistics on the death status of persons with autism spectrum disorder (ASD) are lacking. We aimed to identify and compare recent mortality rates in persons with ASD in Korea. Methods: From 2012 to 2021, databases were established by linking data on persons with ASD registered in Korea with data on cause of death from the National Statistical Office. Results: Between 2012 and 2021, the mortality rate of persons with ASD and age-standardized mortality rates fluctuated annually. The crude mortality rates in the population with ASD were 91.6, 113.8, and 74.5 in 2012, 2016, and 2021, respectively, which were lower than the rates in the general population; however, the age-standardized mortality rate was observed to be five times higher. Intentional self-harm, as a cause of death in persons with ASD, was ranked high annually. The mortality rates in persons with ASD from diseases (50.7%) and injury (49.3%) were in a ratio of 1:1. Diseases and injury were more causes of death in males with ASD. The average age of persons with ASD at death was confirmed to be approximately 50 years lower than that of the general population. Conclusion: Deaths and causes of death in persons with ASD differ from those of the general population. Therefore, preventive measures and efforts are required to reduce avoidable deaths among persons with ASD.
Indexed as
Identifiers
40225248PMC11992906What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.